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Oral session 7 – Onkologi
effects were the primary cause of mortality and morbidity in our cohort. To obtain
more accurate estimates, we are currently updating our cohort with Swedish data.
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Background: In Denmark, all patients diagnosed with acute myeloid leukaemia
(AML) since 2000 have been recorded in the Danish National Acute Leukaemia
Registry (DNLR), which has been proven to be of high quality and having a high
completeness regarding most information. We aimed to describe the quality in the
DNLR concerning treatment response by evaluating complete remission (CR) status
according to the international classification of AML treatment response status as well
as prognosis according to CR status.
Materials & methods: We conducted a retrospective study including data from the
DNLR regarding patients aged ≥ 18 years, diagnosed with non-APL AML, treated
with curative intention, and registered as having achieved CR following first or second
induction treatment. Patients were evaluated as stringent CR (sCR) or non-sCR ac-
cording to international remission criteria. Analysis included estimation of PPV for CR
as being sCR as well as the CR status effect on overall survival and relapse-free survival.
Results: In total 387 patients where included yielding a PPV for CR being sCR
of 48.6% (95% CI: 43.5%–53.7%). Patients achieving sCR had better prognostic
outcomes compared to non-sCR regarding OS when performing univariable analysis
(HR: 1.48, 95% CI: 1.15–1.94, p=0.002) and adjusted multivariable analysis (HR: 1.45,
95% CI: 1.12–1.87, p=0.005).
Conclusions: Our study suggests that the prognosis is dependent of CR being evalu-
ated according to international guidelines, with sCR as best case scenario. Therefore,
it is indicated that there is a need for more attention into more precise response
evaluation using international remission criteria.
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